ConductScience.org, home

Paper18802153

Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Dieu-Nosjean MC and 12 others. J Clin Oncol, 2008. Cited by 828 papers, by iCite.

Cite this record

ConductScience Library. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Papers, record 18802153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18802153

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
PubMed
Journal
J Clin Oncol
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
828
iCite
Relative citation ratio, by iCite
15
iCite
Revised in PubMed
2022-04-19
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dieu-Nosjean MCMarie-Caroline
2Antoine MMartine
3Danel CClaire
4Heudes DDidier
5Wislez MMarie
6Poulot VVirginie
7Rabbe NNathalie
8Laurans LLudivine
9Tartour EEric
10de Chaisemartin LLuc
11Lebecque SSerge
12Fridman WHWolf-Herman
13Cadranel JJacques

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
ChoristomaMajor topic
Lung NeoplasmsMajor topic
Lymph NodesMajor topic
Adult
Aged
Biopsy
CD4 Lymphocyte Count
Cell Count
Female
Humans
Immunohistochemistry
Male
Middle Aged
Neoplasm Staging
Precancerous Conditions
Prognosis
Retrospective Studies
Survival Rate
T-Lymphocyte Subsets

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in18802146Ectopic lymph nodes within human solid tumors.https://conductscience.org/library/papers/18802146

Source PubMed

Download CSV of comments and corrections

Cited by587

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 828 citations.

PMIDTitleJournalYearIn PapersSource
42947476Identification of a Glycosylation-Related Gene Prognostic Signature for Non-Small Cell Lung Cancer.J Gene Med2026https://conductscience.org/library/papers/42947476PubMed
42903730Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive-stage small cell lung cancer.Clin Transl Immunology2026https://conductscience.org/library/papers/42903730PubMed
42898662From density to spatial function: spatial multi-omics, composite biomarker design, and therapeutic engineering of tertiary lymphoid structures in solid tumors.Front Immunol2026https://conductscience.org/library/papers/42898662PubMed
42858224CD8⁺ T Cell infiltration and spatial organization in cancer: mechanisms, barriers, and therapeutic strategies.Mol Biomed2026https://conductscience.org/library/papers/42858224PubMed
42828165Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape.Front Immunol2026https://conductscience.org/library/papers/42828165PubMed
42787593Tertiary lymphoid structures in neoadjuvant and perioperative cancer immunotherapy: a review and proposed framework for biomarker interpretation and validation.Front Immunol2026https://conductscience.org/library/papers/42787593PubMed
42761275Role of Tertiary Lymphoid Structures in Autoimmune Diseases and Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42761275PubMed
42738358Bronchoscopic Ablation and Intratumoral Therapies for Lung Cancer: Expanding Local Treatment Beyond Surgical Resection.Cancers (Basel)2026https://conductscience.org/library/papers/42738358PubMed
42693308Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses.Mol Biomed2026https://conductscience.org/library/papers/42693308PubMed
42613326Humoral immunity in cancer.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42613326PubMed
42598915TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC.Thorac Cancer2026https://conductscience.org/library/papers/42598915PubMed
42566543Formation of tertiary lymphoid structures drives Parkin antitumor immunity.Sci Adv2026https://conductscience.org/library/papers/42566543PubMed
42548652Mechanisms of T cell-mediated antitumor immunity within tertiary lymphoid structures.Front Immunol2026https://conductscience.org/library/papers/42548652PubMed
42468992Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma.J Immunother Cancer2026https://conductscience.org/library/papers/42468992PubMed
42452880Tertiary lymphoid structures in gastrointestinal cancer: orchestrating tumour microenvironmental immune subcycles to elegantly amplify the cancer immunity cycle.Ann Med2026https://conductscience.org/library/papers/42452880PubMed
42449683
Spatial Transcriptomics of Immune Cell Distribution in Non-Small Cell Lung Cancer Identifies Tertiary Lymphoid Structures and Its Density and Area Fraction Were Associated with Neoadjuvant Therapy Response.
Cancers (Basel)2026https://conductscience.org/library/papers/42449683PubMed
42449297The Ki-67 proliferation index in tertiary lymphoid structures as a predictor of survival outcomes in patients with resectable non-small cell lung cancer.BMC Cancer2026https://conductscience.org/library/papers/42449297PubMed
42444407Single-Cell and Spatial Analysis Reveal the Differences Between Left-Sided and Right-Sided Colorectal Cancer.Cell Prolif2026https://conductscience.org/library/papers/42444407PubMed
42350046FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer.J Immunother Cancer2026https://conductscience.org/library/papers/42350046PubMed
42324542Prognostic value of tertiary lymphoid structures in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoimmunotherapy: a retrospective study.J Cardiothorac Surg2026https://conductscience.org/library/papers/42324542PubMed

See all 587 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
TBX2130009PubTator's text mininghttps://conductscience.org/library/genes/30009NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18802153

GET https://conductscience.org/api/papers/v1/18802153/cited_by?page=2